4/A//SEC Filing
THEOFAN GEORGIA 4/A
Accession 0001294002-04-000022
CIK 0000817785other
Filed
Aug 11, 8:00 PM ET
Accepted
Aug 12, 2:00 PM ET
Size
4.9 KB
Accession
0001294002-04-000022
Insider Transaction Report
Form 4/AAmended
THEOFAN GEORGIA
VP, Clinical Development
Transactions
- Purchase
Common Stock
2004-08-11$0.70/sh+5,000$3,500→ 10,475 total
Footnotes (1)
- [F1]The wrong Transaction Code was used on the original filing.
Documents
Issuer
IMMUNE RESPONSE CORP
CIK 0000817785
Entity typeother
Related Parties
1- filerCIK 0001280158
Filing Metadata
- Form type
- 4/A
- Filed
- Aug 11, 8:00 PM ET
- Accepted
- Aug 12, 2:00 PM ET
- Size
- 4.9 KB